Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TSLA vs GSK✓SelectedUSD · GSKTSLA vs GSK performance historyLatest closeAs of+0.95%11/18
Stock and ETF performance explorer

TSLA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-4.4%
GSK return
+7.0%
Excess return
-11.4%
Maximum drawdown
-39.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.9%-1.3%+2.3%+0.8%
7D-1.8%-3.1%+1.3%-2.1%
30D+4.3%-0.9%+5.1%+4.4%
3M+13.9%-4.2%+18.1%+14.0%
6M-6.4%-1.6%-4.8%-5.9%
YTD-14.7%+2.6%-17.3%-10.8%
1Y-4.4%+6.2%-10.6%+0.4%
All-4.4%+7.0%-11.4%+0.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling